Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


15.10.2018

1 Brain Res
1 J Neural Transm (Vienna)
1 J Neurol Neurosurg Psychiatry
2 Lancet Neurol
16 Mov Disord
1 Neurobiol Dis
1 Neurochem Res
4 Neurology
1 Neuron
1 Neuropsychology
1 Neurosci Lett
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Brain Res

  1. RAHMANI F, Saghazadeh A, Rahmani M, Teixeira AL, et al
    Plasma Levels of Brain-Derived Neurotrophic Factor in Patients with Parkinson Disease: A Systematic Review and Meta-Analysis.
    Brain Res. 2018 Oct 5. pii: S0006-8993(18)30510.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  2. BAIZABAL-CARVALLO JF, Alonso-Juarez M, Fekete R
    The frequency and diagnostic accuracy of hand deformities in Parkinson's disease.
    J Neural Transm (Vienna). 2018 Oct 5. pii: 10.1007/s00702-018-1937.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  3. WOJTALA J, Heber IA, Neuser P, Heller J, et al
    Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition.
    J Neurol Neurosurg Psychiatry. 2018 Oct 8. pii: jnnp-2018-319008.
    PubMed     Text format     Abstract available


    Lancet Neurol

  4. ROCCA WA
    The burden of Parkinson's disease: a worldwide perspective.
    Lancet Neurol. 2018 Oct 1. pii: S1474-4422(18)30355.
    PubMed     Text format    


  5. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet Neurol. 2018 Oct 1. pii: S1474-4422(18)30295.
    PubMed     Text format     Abstract available


    Mov Disord

  6. WALDTHALER J, Tsitsi P, Seimyr GO, Benfatto MN, et al
    Eye movements during reading in parkinson's disease: A pilot study.
    Mov Disord. 2018 Oct 8. doi: 10.1002.
    PubMed     Text format    

  7. SMITH AM, Depp C, Ryan BJ, Johnston GI, et al
    Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells.
    Mov Disord. 2018 Oct 7. doi: 10.1002.
    PubMed     Text format     Abstract available

  8. THALER A, Kozlovski T, Gurevich T, Bar-Shira A, et al
    Survival rates among Parkinson's disease patients who carry mutations in the LRRK2 and GBA genes.
    Mov Disord. 2018 Oct 4. doi: 10.1002/mds.27490.
    PubMed     Text format     Abstract available

  9. GREENAMYRE JT
    What's wrong with mitochondria in Parkinson's disease?
    Mov Disord. 2018 Oct 4. doi: 10.1002.
    PubMed     Text format    

  10. VAN DER VELDEN RMJ, Mulders AEP, Drukker M, Kuijf ML, et al
    Network analysis of symptoms in a Parkinson patient using experience sampling data: An n = 1 study.
    Mov Disord. 2018 Oct 4. doi: 10.1002.
    PubMed     Text format     Abstract available

  11. KOROS C, Simitsi A, Prentakis A, Beratis I, et al
    123I-FP-CIT SPECT [(123) I-2beta-carbomethoxy-3beta-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T alpha-synuclein Parkinson's disease cohort versus Parkinson's disease.
    Mov Disord. 2018 Oct 4. doi: 10.1002/mds.27451.
    PubMed     Text format     Abstract available

  12. BEACH TG, Adler CH
    Importance of low diagnostic Accuracy for early Parkinson's disease.
    Mov Disord. 2018 Oct 4. doi: 10.1002/mds.27485.
    PubMed     Text format    

  13. BLAUWENDRAAT C, Bras JM, Nalls MA, Lewis PA, et al
    Coding variation in GBA explains the majority of the SYT11-GBA Parkinson's disease GWAS locus.
    Mov Disord. 2018 Oct 9. doi: 10.1002.
    PubMed     Text format    

  14. HOLDEN SK, Medina LD, Hoyt B, Sillau SH, et al
    Validation of a performance-based assessment of cognitive functional ability in Parkinson's disease.
    Mov Disord. 2018 Oct 10. doi: 10.1002/mds.27487.
    PubMed     Text format     Abstract available

  15. FABER I, Martinez ARM, Martins CR Jr, Maia ML, et al
    SPG11-related parkinsonism: Clinical profile, molecular imaging and l-dopa response.
    Mov Disord. 2018 Oct 10. doi: 10.1002/mds.27491.
    PubMed     Text format     Abstract available

  16. VIRMANI T, Pillai L, Glover A, Doerhoff SM, et al
    Impaired step-length setting prior to turning in Parkinson's disease patients with freezing of gait.
    Mov Disord. 2018 Oct 10. doi: 10.1002/mds.27499.
    PubMed     Text format    

  17. MARAKI MI, Yannakoulia M, Stamelou M, Stefanis L, et al
    Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease.
    Mov Disord. 2018 Oct 10. doi: 10.1002/mds.27489.
    PubMed     Text format     Abstract available

  18. TOSSERAMS A, Araujo R, Pringsheim T, Post B, et al
    Underrepresentation of women in Parkinson's disease trials.
    Mov Disord. 2018 Oct 11. doi: 10.1002/mds.27505.
    PubMed     Text format    

  19. GRONICH N, Abernethy DR, Auriel E, Lavi I, et al
    beta2-adrenoceptor agonists and antagonists and risk of Parkinson's disease.
    Mov Disord. 2018;33:1465-1471.
    PubMed     Text format     Abstract available

  20. VAILLANCOURT DE, Lehericy S
    Illuminating basal ganglia and beyond in Parkinson's disease.
    Mov Disord. 2018;33:1373-1375.
    PubMed     Text format    

  21. GUO L, Normando EM, Shah PA, De Groef L, et al
    Oculo-visual abnormalities in Parkinson's disease: Possible value as biomarkers.
    Mov Disord. 2018;33:1390-1406.
    PubMed     Text format     Abstract available


    Neurobiol Dis

  22. HERNANDO S, Requejo C, Herran E, Ruiz-Ortega JA, et al
    Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation.
    Neurobiol Dis. 2018 Oct 5. pii: S0969-9961(18)30292.
    PubMed     Text format     Abstract available


    Neurochem Res

  23. JIANG Y, Cao Z, Ma H, Wang G, et al
    Auricular Vagus Nerve Stimulation Exerts Antiinflammatory Effects and Immune Regulatory Function in a 6-OHDA Model of Parkinson's Disease.
    Neurochem Res. 2018 Oct 11. pii: 10.1007/s11064-018-2639.
    PubMed     Text format     Abstract available


    Neurology

  24. HELMICH RC, Hallett M, Dirkx MF
    Author response: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:724.
    PubMed     Text format    

  25. JANKOVIC J
    Reader response: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:723.
    PubMed     Text format    

  26. KARAM C, Galetta S
    Editors' note: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:722.
    PubMed     Text format    

  27. GERAEDTS VJ, Boon LI, Marinus J, Gouw AA, et al
    Clinical correlates of quantitative EEG in Parkinson disease: A systematic review.
    Neurology. 2018 Oct 5. pii: WNL.0000000000006473.
    PubMed     Text format     Abstract available


    Neuron

  28. NUBER S, Rajsombath M, Minakaki G, Winkler J, et al
    Abrogating Native alpha-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson's Disease.
    Neuron. 2018;100:75-90.
    PubMed     Text format     Abstract available


    Neuropsychology

  29. EHGOETZ MARTENS KA, Silveira CRA, Intzandt BN, Almeida QJ, et al
    State anxiety predicts cognitive performance in patients with Parkinson's disease.
    Neuropsychology. 2018 Oct 4. pii: 2018-49019-001. doi: 10.1037/neu0000478.
    PubMed     Text format     Abstract available


    Neurosci Lett

  30. FONSECA-FONSECA LA, Wong-Guerra M, Ramirez-Sanchez J, Montano-Peguero Y, et al
    JM-20, a novel hybrid molecule, protects against rotenone-induced neurotoxicity in experimental model of Parkinson's disease.
    Neurosci Lett. 2018 Oct 7. pii: S0304-3940(18)30678.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  31. LEE KS, Huh S, Lee S, Wu Z, et al
    Altered ER-mitochondria contact impacts mitochondria calcium homeostasis and contributes to neurodegeneration in vivo in disease models.
    Proc Natl Acad Sci U S A. 2018;115:E8844-E8853.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: